Folate Fortification and Survival of Children with Acute Lymphoblastic Leukemia

被引：0
|
作者：
Deborah A. Kennedy
Sandy Grupp
Mark Greenberg
Gideon Koren
机构：
[1] The Hospital for Sick Children,The Motherisk Program
[2] University of Toronto,Leslie Dan Faculty of Pharmacy
[3] Pediatric Oncology Group of Ontario (POGO),Department of Pediatrics, Faculty of Medicine
[4] University of Toronto,Division of Clinical Pharmacology/Toxicology
[5] Hospital for Sick Children,undefined
来源：
Pediatric Drugs | 2011年 / 13卷
关键词：
Folate; Acute Lymphoblastic Leukemia; Bone Marrow Transplant; Spina Bifida; Neural Tube Defect;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The antifolate drug methotrexate is a mainstay of treatment for children diagnosed with acute lymphoblastic leukemia (ALL). There have been concerns regarding the impact of folate fortification on the efficacy of methotrexate therapy and hence treatment outcomes of ALL.
引用
收藏
页码：193 / 196
页数：3
相关论文
共 50 条
  • [41] A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia
    Lupo, Philip J.
    Nousome, Darryl
    Kamdar, Kala Y.
    Okcu, M. Fatih
    Scheurer, Michael E.
    CANCER CAUSES & CONTROL, 2012, 23 (11) : 1797 - 1803
  • [42] Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia
    Petersen, KB
    Jusko, WJ
    Rasmussen, M
    Schmiegelow, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (06) : 465 - 473
  • [43] Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia
    Kamilla B. Petersen
    William J. Jusko
    Mette Rasmussen
    Kjeld Schmiegelow
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 465 - 473
  • [44] TOLERABILITY OF PREDNISONE AND DEXAMETHASONE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Ragkovic, A.
    Rakic, B.
    Kolarovic, J.
    Konstantinidis, N.
    Milijasevic, B.
    Mikov, M.
    Sabo, A.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E142 - E142
  • [45] Characteristics of children with acute lymphoblastic leukemia presenting with arthropathy
    Ninna Brix
    Henrik Hasle
    Steen Rosthøj
    Troels Herlin
    Clinical Rheumatology, 2018, 37 : 2455 - 2463
  • [46] Bone Mineral Density in Children With Acute Lymphoblastic Leukemia
    Inaba, Hiroto
    Cao, Xueyuan
    Han, Alice Q.
    Panetta, John C.
    Ness, Kirsten K.
    Metzger, Monika L.
    Rubnitz, Jeffrey E.
    Ribeiro, Raul C.
    Sandlund, John T.
    Jeha, Sima
    Cheng, Cheng
    Pui, Ching-Hon
    Relling, Mary V.
    Kaste, Sue C.
    CANCER, 2018, 124 (05) : 1025 - 1035
  • [47] Cognitive Emotion Regulation in Children with Acute Lymphoblastic Leukemia
    Firoozi, M.
    Besharat, M. A.
    Tehrani, Pournaghash S.
    IRANIAN JOURNAL OF CANCER PREVENTION, 2011, 4 (04) : 183 - 188
  • [48] Thyroid function in children treated for acute lymphoblastic leukemia
    A. Mohn
    F. Chiarelli
    A. Di Marzio
    P. Impicciatore
    S. Marsico
    F. Angrilli
    Journal of Endocrinological Investigation, 1997, 20 : 215 - 219
  • [49] Acute lymphoblastic leukemia: Optimizing treatment strategies in children
    Vora A.
    Pediatric Drugs, 2002, 4 (6) : 405 - 416
  • [50] Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia
    Kaluzna, Ewelina
    Strauss, Ewa
    Zajac-Spychala, Olga
    Gowin, Ewelina
    Swiatek-Koscielna, Bogna
    Nowak, Jerzy
    Fichna, Marta
    Mankowski, Przemyslaw
    Januszkiewicz-Lewandowska, Danuta
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 769 : 93 - 99
12345